Cha Biotech's U.S. CDMO arm inks vector deal with Cirsium

Matica Biotechnology, the U.S. contract development and manufacturing organization arm of Cha Biotech, announced Tuesday that it signed an agreement with Cirsium Biosciences to produce the California-based firm's vectors.